UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029125
Receipt number R000028192
Scientific Title A prospective pilot study of the usefulness of l-menthol as antispasmodic drug during ERCP.
Date of disclosure of the study information 2017/09/26
Last modified on 2017/09/13 11:15:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective pilot study of the usefulness of l-menthol as antispasmodic drug during ERCP.

Acronym

The usefulness of l-menthol in ERCP

Scientific Title

A prospective pilot study of the usefulness of l-menthol as antispasmodic drug during ERCP.

Scientific Title:Acronym

The usefulness of l-menthol in ERCP

Region

Japan


Condition

Condition

Bile duct stone

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the validity and safety of l-menthol as antispasmodic drug in ERCP

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Rate of complete procedure planned without additional antispasmodic drugs

Key secondary outcomes

Time to deep cannulation into common bile duct or pancreatic duct
total procedure time
Complications related to the procedures


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

l-menthol

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who performed diagnostic ERCP for pancreatic or biliary diseases.

Key exclusion criteria

1) Patients with previous gastrectomy.
2) Patients with allergic for l-menthol.
3) Patients with severe complications of other organs.
4) Pregnant patients or patients who were suspected pregnancy.
5) Patients whose informed consent could not be obtained.
6) In case that doctors judged inappropriate for the entry.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masatoshi Mabuchi

Organization

Mizonokuchi Hospital Teikyo University School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

3-8-3, Mizonokuchi, Takatsu-ku, Kawasaki, Kanagawa 213-8507 JAPAN

TEL

044-844-3333

Email

masatoshi.mabuchi@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Masatoshi Mabuchi

Organization

Mizonokuchi Hospital Teikyo University School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

3-8-3, Mizonokuchi, Takatsu-ku, Kawasaki, Kanagawa 213-8507 JAPAN

TEL

044-844-3333

Homepage URL


Email

masatoshi.mabuchi@gmail.com


Sponsor or person

Institute

Teikyo University Mizonokuchi Hospital Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

帝京大学医学部附属溝口病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 13 Day

Last modified on

2017 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028192


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name